Silicon Laboratories (BSP:S2LA34) Cyclically Adjusted Revenue per Share: R$0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:S2LA34 Silicon Laboratories Inc BSP:S2LA34
48 GF Score
Price R$50.70
GF Value R$37.13
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Silicon Laboratories Cyclically Adjusted Revenue per Share?

Silicon Laboratories BSP:S2LA34 +0.90% 48 Cyclically Adjusted Revenue per Share is R$0.00 as of Mar. 2026. GuruFocus rates BSP:S2LA34 with a GF Score™ of 48/100 and a GF Value™ of R$37.13 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Note: As Cyclically Adjusted Revenue per Share is a main component used to calculate Cyclically Adjusted PS Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Silicon Laboratories's adjusted revenue per share for the three months ended in Mar. 2026 was R$33.872. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$0.00 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Silicon Laboratories's average Cyclically Adjusted Revenue Growth Rate was 5.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.20% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 6.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Silicon Laboratories was 14.30% per year. The lowest was 4.30% per year. And the median was 8.10% per year.

As of today (2026-07-29), Silicon Laboratories's current stock price is R$50.70. Silicon Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was R$0.00. Silicon Laboratories's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Silicon Laboratories was 12.34. The lowest was 4.18. And the median was 6.57.


Silicon Laboratories  (BSP:S2LA34) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Silicon Laboratories was 12.34. The lowest was 4.18. And the median was 6.57.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Silicon Laboratories Cyclically Adjusted Revenue per Share Related Terms


Silicon Laboratories Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Silicon Laboratories's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Silicon Laboratories Cyclically Adjusted Revenue per Share Chart

Silicon Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Silicon Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BSP:S2LA34 vs CRUS, QRVO, MXL: Cyclically Adjusted Revenue per Share Comparison

For the Semiconductors subindustry, Silicon Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Silicon Laboratories Cyclically Adjusted PS Ratio vs Semiconductors Industry

For the Semiconductors industry and Technology sector, Silicon Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Silicon Laboratories's Cyclically Adjusted PS Ratio falls into.


BSP:S2LA34
48GF Score
Silicon Laboratories Inc BSP:S2LA34
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Silicon Laboratories Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Silicon Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=33.872/330.2130*330.2130
=33.872

Current CPI (Mar. 2026) = 330.2130.

Silicon Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 14.161 241.018 19.402
201609 13.694 241.428 18.730
201612 14.339 241.432 19.612
201703 13.012 243.801 17.624
201706 14.509 244.955 19.559
201709 14.352 246.819 19.201
201712 15.141 246.524 20.281
201803 15.334 249.554 20.290
201806 18.483 251.989 24.221
201809 21.406 252.439 28.001
201812 19.122 251.233 25.133
201903 16.527 254.202 21.469
201906 18.370 256.143 23.682
201909 20.609 256.759 26.505
201912 -13.223 256.974 -16.992
202003 23.654 258.115 30.261
202006 13.558 257.797 17.366
202009 16.169 260.280 20.513
202012 16.774 260.474 21.265
202103 19.409 264.877 24.197
202106 18.627 271.696 22.639
202109 21.861 274.310 26.316
202112 28.727 278.802 34.024
202203 29.440 287.504 33.813
202206 36.288 296.311 40.440
202209 40.680 296.808 45.258
202212 40.578 296.797 45.147
202303 38.083 301.836 41.663
202306 36.096 305.109 39.066
202309 31.371 307.789 33.657
202312 13.361 306.746 14.383
202403 16.601 312.332 17.551
202406 24.373 314.175 25.617
202409 28.520 315.301 29.869
202412 31.284 315.605 32.732
202503 31.520 319.799 32.546
202506 32.724 322.561 33.500
202509 33.646 324.800 34.207
202512 34.509 324.054 35.165
202603 33.872 330.213 33.872

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of R$0.00 mean?
Silicon Laboratories (BSP:S2LA34) has a Cyclically Adjusted Revenue per Share of R$0.00 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Silicon Laboratories and its competitors.
Is Silicon Laboratories' Cyclically Adjusted Revenue per Share too high?
Silicon Laboratories' current Cyclically Adjusted Revenue per Share is R$0.00. Overall, Silicon Laboratories has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Silicon Laboratories' Cyclically Adjusted Revenue per Share compare to CRUS and QRVO?
Silicon Laboratories' Cyclically Adjusted Revenue per Share of R$0.00 can be compared against companies in the Semiconductors industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Semiconductors company?
A good Cyclically Adjusted Revenue per Share depends on the Semiconductors industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Silicon Laboratories and its competitors. Silicon Laboratories's current Cyclically Adjusted Revenue per Share is R$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Silicon Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Silicon Laboratories (BSP:S2LA34) is currently considered Significantly Overvalued. The stock's GF Value™ is R$37.13, compared to a current price of R$50.70 — trading 36.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is R$0.00. Silicon Laboratories' overall GF Score™ is 48/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Silicon Laboratories (BSP:S2LA34), the current Cyclically Adjusted Revenue per Share is R$0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Silicon Laboratories (BSP:S2LA34) Overvalued in 2026?

Based on GuruFocus' analysis, Silicon Laboratories stock appears to be overvalued. The current stock price of R$50.70 is trading 36.5% above its estimated GF Value™ of R$37.13. GuruFocus considers Silicon Laboratories to be Significantly Overvalued.

Key valuation signals for BSP:S2LA34:

  • Cyclically Adjusted Revenue per Share: R$0.00
  • GF Value™: R$37.13 vs. price of R$50.70 (36.5% above fair value)
  • GF Score™: 48/100 with 5 warning signs

No single metric tells the full story. See the BSP:S2LA34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Silicon Laboratories Business Description

Other Exchanges SLAB:USALA5:Germany
Address 400 West Cesar Chavez, Austin, TX, USA, 78701
Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.
48GF Score

Get the complete analysis for BSP:S2LA34

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$50.70
Price
R$37.13
GF Value